SitemapImpressumDatenschutzerklärungdeutschenglish
MHH Logo

Funding & Collaborations

Funding (Selection):

  • EU projects:
  1. HOMAGE: Heart OMics in AGEing (2013 – 2019)
  2. ERC Grant LONGHEART: Exploring selected long non-coding RNAs as diagnostics and therapeutic targets for heart failure (2015 – 2020)
  3. CARDIOREGENIX: Development of Next-Generation Gene Therapies (2019 – 2023)
  4. EU funding via N-Bank - im Rahmen des Niedersächsischen Innovationsförderprogramms für Forschung und Entwicklung in Unternehmen: Entwicklung einer Kardiomyozyten-spezifischen CHAST-Therapie zur Behandlung von chronischer Herzschwäche (zusammen mit Cardior Pharmaceuticals GmbH, 2018 – 2021)
  • Leducq Foundation: Trans-Atlantic Network and Training Program on MicroRNA-Based Therapeutic Strategies in Vascular Disease (MIRVAD, 2014 – 2019)*
  • DFG:
  1. TH903/18-1 (with ANR): Regulation, diagnostics and therapy focusing on the mineralocorticoid receptor involved in cardiac remodeling (2016 – 2020)
  2. TH903/19-1 (with ANR): CARDINAL - Cardiomyocyte-derived vesicular non coding RNAs and post-ischemic cardiac remodeling (2016 – 2020)
  3. TH903/20-1 (KFO 311): (Prä-)terminales Herz- und Lungenversagen: Mechanische Entlastung und Reparatur, Teilprojekt 9 (2016 – 2019)
  4. TH903/22-1 (FOR 2591): Severity assessment in animal based research (2017 – 2020)
  5. BA5631/2-1: Funktionelle und molekulare Analyse von Telomerase bei der Kardiomyozyten-Proliferation und Herzregeneration (2017 – 2020)
  6. REBIRTH – Cluster of Excellence (since 2006)
  • European Research Area Network (ERA-Net) projects: ERA-CVD/BMBF, Projektträger DLR
  1. EXPERT: Exploring new pathways in age-related heart diseases (Analyse RNA-basierter Signalwege in altersbedingten Herzerkrankungen; 2017 - 2020) *
  2. LIPCAR: LIPCAR, a prognostic marker of heart failure with reduced ejection fraction (LIPCAR, ein prognostischer Biomarker bei Herzinsuffizienz; 2017 - 2020)
  3. INNOVATION: Investigating long non-coding RNA regulated pathways driving cardiac regeneration (Untersuchung von RNA-vermittelten Signalwegen in der myokardialen Regeneration, grant to Dr. Christian Bär within the ERA-CVD Joint Transnational Call 2018 „Transnational Call 2018 for cardiovascular research projects driven by Early Career Scientists; 2019 – 2022)*
  • Industry (different projects)

* co-ordinating party